OpenR25NIDAClinical trial: Not allowed
Notice of Early Expiration of PAR-25-204, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"
National Institute on Drug Abuse (NIDA) · NIH Institute/Center · NOT-DA-26-015
Source: NIH Guide for Grants & Contracts · View original posting ↗
Newly posted to the NIH Guide — see the notice for key dates.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Amount not listed
- DeadlineFinal application due date.
- Not set
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- R25
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Unknown
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- —
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Not allowed
Research areas
Training & career development
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Notice NOT-DA-26-015 from the NIH Guide for Grants and Contracts